POET to Demonstrate Cutting-Edge Light Source and Industry-leading 1.6T Optical Engines for AI Applications at OFC Conference

(TSX-V:PTK),(NASDAQ:POET), TORONTO, March 25, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company“) (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced it plans to demonstrate its latest technology innovations and products at the Optical Fiber Communications […]

FE International Advises on the Acquisition of Heywood Business Analysts by Regnology

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) — FE International, a leading global M&A advisor for technology businesses, is pleased to announce the acquisition of Heywood Business Analysts, an IT software development company by Regnology, a prominent software provider specializing in regulatory reporting solutions backed by Nordic Capital. Founded in 1996 by Christopher Strangways-Dixon, Heywood

Dr. Sandeep Rout Joins Locus Technologies to Drive EHS Software Adoption

MOUNTAIN VIEW, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Locus Technologies, the sustainability and Environmental Health and Safety (EHS) compliance software leader, welcomed Sandeep Rout, PhD, MBA, as Director of Customer Success, effective immediately. Dr. Rout will leverage more than two decades of expertise in the EHS domain, mostly with Global Oil & Gas and

NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors

(NasdaqGM:NTHI), WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, announced today that it has appointed Bader Almonawer, Managing Partner at Arabian Group, a provider of insurance solutions, to its Board of Directors. Almonawer

Eterna Therapeutics Changes Name to Ernexa Therapeutics to Reflect New Strategic Focus on Ovarian Cancer and Autoimmune Disease

(NASDAQ:ERNA), Ernexa Therapeutics embarks on new strategic direction, shifting the company's focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company's unwavering commitment to patient impact,“Breaking Through Defenses, Delivering Hope” CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) — Eterna Therapeutics, a leader in cell therapies for the treatment

Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease

(NASDAQ:GNLX), – U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support traditional approval – WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Genelux has concluded a productive Type D meeting with the

Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

(NASDAQ:GNLX), – Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a reduction in all target lesions, with one participant achieving a tumor reduction of approximately 79%. – Additionally, three participants, including one individual with three prior

Vocodia to Launch Groundbreaking AI Platform for Developers, Enabling Voice, Chat, and Phone Support in Under 15 Minutes

(PinkSheets:VHAI),(Pinksheets:VHAI), BOCA RATON, Fla., March 25, 2025 (GLOBE NEWSWIRE) — Vocodia Holdings Corp. (OTC: VHAI), a leading innovator in artificial intelligence for communications, announced today the upcoming release of its powerful new platform designed specifically for the developer market. The platform is expected to open to users within the next 30 to 45 days. This

Corporate and Municipal CUSIP Request Volumes Increase in February

NORWALK, Conn., March 25, 2025 (GLOBE NEWSWIRE) — CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for February 2025. The report, which tracks the issuance of new security identifiers as an early indicator of debt and capital markets activity over the next quarter, found a strong monthly increase in

The Children’s Place to Release Fourth Quarter and Year-End Fiscal 2024 Financial Results and Letter to Shareholders

(NASDAQ:PLCE), SECAUCUS, N.J., March 25, 2025 (GLOBE NEWSWIRE) — The Children's Place, Inc. (Nasdaq: PLCE), the largest pure-play children's specialty retailer in North America with an omni-channel portfolio of brands and an industry-leading digital-first model, today announced that their fourth quarter and year-end fiscal 2024 financial results, and Turki S. AlRajhi's annual letter to shareholders,

Scroll to Top